Ryan Daws
2014
In 2014, Ryan Daws earned a total compensation of $1.9M as Chief Financial Officer at Concert Pharmaceuticals.
Compensation breakdown
| Bonus | $97,000 |
|---|---|
| Non-Equity Incentive Plan | $88,647 |
| Option Awards | $1,389,273 |
| Salary | $282,358 |
| Other | $47,224 |
| Total | $1,904,502 |
Daws received $1.4M in option awards, accounting for 73% of the total pay in 2014.
Daws also received $97K in bonus, $88.6K in non-equity incentive plan, $282.4K in salary and $47.2K in other compensation.
Rankings
In 2014, Ryan Daws' compensation ranked 4,721st out of 13,032 executives tracked by ExecPay. In other words, Daws earned more than 63.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,721 out of 13,032 | 64th |
Division Manufacturing | 1,691 out of 4,966 | 66th |
Major group Chemicals And Allied Products | 554 out of 1,686 | 67th |
Industry group Drugs | 424 out of 1,365 | 69th |
Industry Pharmaceutical Preparations | 337 out of 1,043 | 68th |
Source: SEC filing on April 20, 2015.
Daws' colleagues
We found two more compensation records of executives who worked with Ryan Daws at Concert Pharmaceuticals in 2014.